"Our study suggests that liraglutide may be an appropriate additional treatment option in people with overweight or obesity, COPD and OSA," the authors wrote. This study was led by Sofie Krogh Wolsing ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities. Obstructive sleep apnea syndrome (OSAS), on the other hand, is usually ...

Researchers from Humana Healthcare Research and University of Chicago Medicine found that Medicare Advantage members with COPD and low medication adherence significantly improved their ...

Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, affects more than 30 million ...

Guiding people on how to correctly use inhaled medications via a phone-based program can help improve technique, according to ...

AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...

AstraZeneca (AZN) stock is in focus as tozorakimab marks a new Phase 3 trial win in chronic obstructive pulmonary disease, a ...

(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

Chasing a good night’s sleep? Seven hours of blissful, undisturbed snoozing could very well involve limiting caffeine intake, drinking chamomile tea and avoiding blue light before bedtime. But if ...

Improve your sleep with one of our favorite pillows for sleep apnea, with something for every sleep preference and price ...

Eli Lilly's weight loss pill Foundayo was approved by the FDA. The pill rivals GLP-1 weight loss medications from other major drugmakers, like Novo Nordisk. Here's everything to know about side ...